{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:08:37Z","timestamp":1778285317787,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.therap.2023.02.010","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T21:46:52Z","timestamp":1677102412000},"page":"585-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview"],"prefix":"10.1016","volume":"78","author":[{"given":"Sophie","family":"Billioti de Gage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Desplas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Dray-Spira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2023.02.010_bib0090","unstructured":"Conseil national du sida et des h\u00e9patites virales (CNS). Prise en charge m\u00e9dicale des personnes vivant avec le VIH. Recommandations du groupe d\u2019experts - Actualisation. 2015\u00a0: prophylaxie pr\u00e9-exposition. http:\/\/www.cns.sante.fr\/spip.php?article537.[Accessed 20 February 2023]."},{"key":"10.1016\/j.therap.2023.02.010_bib0095","unstructured":"Haute autorit\u00e9 de sant\u00e9 (HAS). Recommandation relative \u00e0 la prise en charge \u00e0 titre d\u00e9rogatoire de Truvada (emtricitabine\/fumarate de tenofovir disoproxil) dans le cadre d\u2019une recommandation temporaire d\u2019utilisation. 2015. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2015-12\/truvada_annexe_rtu_has_2015.pdf. [Accessed 20 February 2023 (11 pp.)]."},{"key":"10.1016\/j.therap.2023.02.010_bib0100","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2023.02.010_bib0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2023.02.010_bib0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/QAI.0000000000002107","article-title":"HIV Seroconversion in the era of pharmacologic prevention: a case-control study at a San Francisco STD Clinic","volume":"82","author":"Johnson","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.therap.2023.02.010_bib0115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/QAI.0000000000002646","article-title":"Population-level effectiveness of HIV pre-exposure prophylaxis among MSM and transgender persons with bacterial sexually transmitted infections","volume":"87","author":"Pagkas-Bather","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.therap.2023.02.010_bib0120","doi-asserted-by":"crossref","first-page":"100486","DOI":"10.1016\/j.lanepe.2022.100486","article-title":"Roll-out of HIV pre-exposure prophylaxis use in France: a nationwide observational study from 2016 to 2021","volume":"22","author":"Billioti de Gage","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.therap.2023.02.010_bib0125","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/S2468-2667(22)00106-2","article-title":"Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study","volume":"7","author":"Jourdain","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.therap.2023.02.010_bib0130","doi-asserted-by":"crossref","first-page":"i2002","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"Weill","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2023.02.010_bib0135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.2017.21269","article-title":"Association of hysteroscopic vs laparoscopic sterilization with procedural, gynecological, and medical outcomes","volume":"319","author":"Bouillon","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2023.02.010_bib0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2021.21699","article-title":"Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in people aged 75 years or older","volume":"327","author":"Jabagi","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2023.02.010_bib0145","unstructured":"Molina J, Ghosn J, Algarte-Genin M, Rojas-Castro D, Beniguel L, Pialoux G, et al. Incidence of HIV-Infection with daily or on demand PrEP with TDF\/FTC in the Paris area: an update of the prevenir study. Virtual conference: conference on retroviruses and opportunistic infections (CROI). 2021. http:\/\/www.croiwebcasts.org\/console\/player\/48225?mediaType=slideVideo&. [Accessed 20 February 2023]."},{"key":"10.1016\/j.therap.2023.02.010_bib0150","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/jac\/dkz220","article-title":"First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate\/emtricitabine","volume":"74","author":"Siguier","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.therap.2023.02.010_bib0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09540121.2020.1739219","article-title":"Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017)","volume":"32","author":"Annequin","year":"2020","journal-title":"AIDS Care"},{"key":"10.1016\/j.therap.2023.02.010_bib0160","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/QAI.0000000000002620","article-title":"Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries","volume":"87","author":"Rao","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.therap.2023.02.010_bib0165","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1007\/s10461-020-02894-2","article-title":"Characterizing the impact of COVID-19 on men who have sex with men across the United States in April, 2020","volume":"24","author":"Sanchez","year":"2020","journal-title":"AIDS Behav"},{"key":"10.1016\/j.therap.2023.02.010_bib0170","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1186\/s12913-021-07131-7","article-title":"Estimated impact of COVID-19 on preventive care service delivery: an observational cohort study","volume":"21","author":"Laing","year":"2021","journal-title":"BMC Health Serv Res"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:56:25Z","timestamp":1758567385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595723000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0040595723000471"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2023.02.010","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2023.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}